Friday, March 19, 2021 8:57:47 AM
Recent CPRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2025 10:00:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2025 06:23:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 09:26:34 PM
- Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/05/2025 09:06:45 PM
- Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work • GlobeNewswire Inc. • 11/04/2025 09:03:00 PM
- Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 11/03/2025 01:03:00 PM
- Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025 • GlobeNewswire Inc. • 10/22/2025 12:03:00 PM
- Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences • GlobeNewswire Inc. • 10/09/2025 12:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 08:31:13 PM
- Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program • GlobeNewswire Inc. • 10/01/2025 12:03:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2025 09:00:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2025 09:00:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/04/2025 03:28:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/03/2025 04:19:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2025 09:00:04 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/28/2025 08:30:37 PM
- Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/28/2025 12:03:00 PM
- UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals • GlobeNewswire Inc. • 08/26/2025 11:12:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2025 05:07:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2025 02:46:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2025 08:30:16 PM
- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals • GlobeNewswire Inc. • 08/25/2025 12:03:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2025 09:00:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2025 08:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2025 08:50:00 PM
ECGI Appoints AI Platform Architect as CTO to Build Mortgage Tokenization Infrastructure • ECGI • Nov 13, 2025 8:30 AM
Alliance Creative Group (ACGX) Releases 2025 Q3 Quarterly Financial and Disclosure Report • ACGX • Nov 13, 2025 4:40 AM
The Hidden Force Behind the AI Revolution • META • Nov 12, 2025 9:00 AM
The Clean Energy Breakthrough That Could Power the AI Era • MAXXF • Nov 12, 2025 9:00 AM
ECGI Highlights Fintech Expansion Through RezyFi Acquisition and Tokenized Mortgage Platform in Shareholder Letter • ECGI • Nov 11, 2025 8:30 AM
The New Gold Rush of the AI Era • ESAU • Nov 10, 2025 9:00 AM
